Melatonin may improve sleep, quality of life in patients with breast cancer

the ONA take:

Melatonin may be a potential therapeutic agent for improve sleep and quality of life in patients with metastatic breast cancer, according to a new study published online ahead of print in the journal Supportive Care in Cancer.

Because fatigue and sleep problems are common among patients with cancer, researchers at the Sunnybrook Odette Cancer Centre in Toronto, Ontario, sought to investigate the effectiveness of melatonin at improving sleep.

For the phase 2 study, researchers enrolled 32 patients with metastatic breast cancer who were receiving hormonal or trastuzumab therapy. All participants took melatonin 5 mg at bedtime for 2 months.

Results showed that bedtime melatonin was associated with a significant improvement in subjective sleep, fatigue severity, sleep fragmentation and quantity, and quality of life.

The findings suggest that further research assessing the efficacy of melatonin for improving sleep and quality of life in patients with cancer is warranted.

Shift worker more likely to be overweight, experience sleep problems
Melatonin may be a potential therapeutic agent for improve sleep and quality of life in patients with metastatic breast cancer.
Fatigue and sleep problems are prevalent in cancer patients and can be associated with disruption of circadian rhythmicity. In this prospective phase II trial, we sought to assess the effect of melatonin on circadian biomarkers, sleep, and quality of life in breast cancer patients.
READ FULL ARTICLE From Springer
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs